Abstract
Inhibition of atrial natriuretic peptide (ANP) degradation by enkephalinase is known to increase endogenous ANP levels and to induce similar functional effects as administration of exogenous ANP. The influence of this principle on cardiac function in rats with hypertension-induced heart failure was investigated.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Marsh EA, Seymor AA, Haley AB, Whinnery MA, Napier MA, Nutt RF, Blain EH (1985) Renal and blood pressure responses to synthetic atrial natriuretic factor in spontaneously hypertensive rats. Hypertension 7: 386 - 391
Gellai M, DeWolf RE, Kinter LB, Beeuwkes R III (1986) The effect of atrial natriuretic factor on blood pressure, heart rate, and renal functions in conscious, spontaneously hypertensive rats. Circ Res 59: 56 - 62
Imada T, Takayanagi R, Inagami T (1985) Changes in the content of atrial natriuretic factor with the progression of hypertension in spontaneously hypertensive rats. Biochem Biophys Res Commun 133: 759 - 765
Gutkowska J, Kuchel O, Racz K, Buu NT, Cantin M, Genest J (1986) Increased plasma immunoreactive atrial natriuretic factor concentrations in salt sensitive Dahl rats. Biochem Biophys Res Commun 136: 411 - 416
Gutkowska J, Horky K, Lachance C, Racz K, Garcia R, Thibault G, Kuchel O, Genest J, Cantin M (1986) Atrial natriuretic factor in spontaneously hypertensive rats. Hypertension 8 [Suppl I]: I-137-I-140
Kohno M, Sambhi MP, Eggena P, Clegg K, Kanayama Y, Takaori K, Takeda T (1986) An accelerated increase of circulating atrial natriuretic polypeptide in salt- loaded spontaneously hypertensive rats. Horm Metab Res 18: 147 - 148
Morii N, Nakao K, Kihara M, Sugawara A, Sakamoto M, Yamori Y, Imura H (1986) Decreased content in left atrium and increased plasma concentration of atrial natriuretic polypeptide in spontaneously hypertensive rats ( SHR) and SHR stroke-prone. Biochem Biophys Res Commun 135: 74-81
Garcia R, Thibault G, Cantin M (1987) Correlation between cardiac hypertrophy and plasma levels of atrial natriuretic factor in non-spontaneous models of hypertension in the rat. Biochem Biophys Res Commun 145: 532 - 541
Cantin M, Garcia R, Thibault G, Kuchel O, Gutkowska J, Larochelle P, Hamet P, Schiffrin EL, Genest J Atrial natriuretic factor in experimental and human hypertension. Eur Heart J 9 [Suppl H]: 21-27
Koehn JA, Norman JA, Jones BN et al (1987) Degradation of atrial natriuretic factor by kidney cortex membranes. J Biol Chem 262: 11623 - 11627
Sonnenberg JL, Sakane Y, Jeng AY et al (1988) Identification of protease 3.4.21.11 as the major atrial natriuretic factor degrading enzyme in the rat kidney. Peptides 9: 173 - 180
Maaek T, Suzuki M, Almeida FA et al (1987) Physiological role of silent receptors of atrial natriuretic factor. Science 238: 675 - 678
Dussaule JC, Grange JD, Wolf JP, Lecomte JM, Gros C, Schwartz JC, Bodin F, Ardaillou R (1991) Effect of Sinorphan, an enkephalinase inhibitor, on plasma atrial natriuretic factor and sodium urinary excretion in cirrhotic patients with ascites. J Clin Endocrinol Metab 72: 653 - 659
Watkins RW, Vemulapalli S, Chiu PJS, Foster C, Smith EM, Neustadt B, Haslanger M, Sybertz EJ (1993) Atrial natriuretic factor potentiating and hemodynamic effects of SCH 42495, a new, neutral metalloendopeptidase inhibitor. Am J Hypertens 6: 357 - 368
Valentin JP, Qiu C, Wiedemann E, Gardner D, Humphreys MH (1992) Inhibition of neutral endopeptidase amplifies the effects of endogenous atrial natriuretic peptide on blood pressure and fluid partition. Am J Hypertens 5: 88 - 91
Lefrancois P, Clerc G, Duchier J, Lim C, Lecomte JM, Gros C, Schwartz JC (1990) Antihypertensive activity of sinorphan. Lancet 336: 307 - 308
Dussaule JC, Michel C, Peraldi MN, Lecomte JM, Gros C, Mignon F, Ardaillou R (1993) Inhibition of neutral endopeptidase stimulates renal sodium excretion in patients with chronic renal failure. Clin Sei 84: 31 - 39
Kahn JC, Patey M, Dubois-Rande JL, Merlet P, Castaigne A, Lim-Alexandre C, Lecomte JM, Duboc D, Gros C, Schwartz JC (1990) Effect of sinorphan on plasma atrial natriuretic factor in congestive heart failure. Lancet 335: 118 - 119
Giros B, Gros C, Schwartz JC, Danvy D, Plaquevent JC, Duhamel L, Duhamel P, Vlaiculescu A, Costentin J, Lecomte JM (1987) Enantiomers of thiorphan and acetorphan: correlation between enkephalinase inhibition, protection of endogenous enkephalins and behavioral effects. J Pharmacol Exp Ther 243: 666 - 673
Lecomte JM, Baumer P, Lim C, Duchier J, Cournot A, Dussaule JC, Ardaillou R, Gros C, Chaignon B, Souque A, Schwartz JC (1990) Stereoselective protection of exogenous and endogenous atrial natriuretic factor by enkephalinase inhibitors in mice and-humans. Eur J Pharmacol 179: 65 - 73
John A, Stasch JP, Neuser D, Hirth C, Morich F (1986) The use of a monoclonal antibody to measure plasma atriopeptins in the rat. Life Sei 38: 1991 - 1997
Stasch JP, Hirth-Dietrich C, Kazda S, Neuser D (1990) Role of endogenous ANP on endoerine function investigated with a monoclonal antibody. Peptides 11: 577 - 582
Chien Y, Barbee RW, MacPhee AA, Fröhlich ED, Trippodo NC (1987) Increased atrial natriuretic factor (ANF) secretion after volume expansion is preserved in rats with heart failure. Council for High Blood Pressure Research, 4Ist annual fall con- ference, 13-16, Oct New Orleans, abstract 70
Noresson E, Rickstein SE, Thoren P (1979) Left atrial pressure in normotensive and spontaneously hypertensive rats. Acta Physiol Scand 107: 9 - 12
Lang RE, Tholken H, Ganten D et al (1985) Atrial natriuretic factor - a circulating hormone stimulated by volume loading. Nature 314: 264 - 266
Ando SI, Imaizumi T, Harada S, Hirooka Y, Takeshita A (1992) Atrial natriuretic peptide increases human capillary filtration and venous distensibility. J Hypertens 10: 451 - 457
Volpe M, Sosa RE, Müller FB, Camargo MJF, Glorioso N, Laragh JH, Maack T, Atlas SA (1986) Differing hemodynamic responses to atrial natriuretic factor in two models of hypertension. Am J Physiol 250 (Heart Circ Physiol 19): H871 - H878
Simchon S, Manger WM, Carlin RD, Peeters LL, Rodriguez J, Batista D, Brown T, Merchant NB, Jan KM, Chien S (1989) Salt-induced hypertension in Dahl saltsensitive rats. Hemodynamics and renal responses. Hypertension 13: 612-621
Sasaki A, Kida O, Kangawa K et al (1985) Cardiosuppressive effect of or-human atrial natriuretic polypeptide (ahANP) in spontaneously hypertensive rats. Eur J Pharmacol 115: 321 - 324
Kazda S, Knorr A (1990) Calcium antagonists. In: Ganten D, Mulrow PJ (eds) Pharmacology of antihypertensive therapeutics. Springer, Berlin Heidelberg New York pp 301-375 (Handbook of experimental pharmacology, vol 93 )
Garcia R, Thibault G, Gutkowska J, Hamet P, Cantin M, Genest J (1985) Effect of chronic infusion of synthetic atrial natriuretic factor (ANF 8-33) in conscious two- kidney, one-clip hypertensive rats. Proc Soc Exp Biol Med 178: 155 - 159
Cachofeiro V, Schniffrin EL, Thibault G, Cantin M, Garcia R (1989) Effect of a chronic infusion of atrial natriuretic factor on glomerular and vascular receptors in spontaneously hypertensive rats. J Hypertens 7: 335 - 342
Garcia R, Gutkowska J, Genest J, Cantin M, Thibault G (1985) Reduction of blood pressure and increased diuresis and natriuresis during chronic infusion of atrial natriuretic factor (ANF Arg 101-Tyr 126) in conscious one-kidney, one-clip hypertensive rats. Proc Soc Exp Biol 179: 539 - 545
Blaine EH, Heinel LA, Schorn TW, Marsh EA, Whinnery MA (1986) The character of the atrial natriuretic response: pressure and volume effects. J Hypertens 4: S17 - S24
Gerzer R, Witzgall H, Tremblay J, Gutkowska J, Hamet P (1985) Rapid increase in plasma and urinary cyclic GMP after bolus injection of atrial natriuretic factor in man. J Clin Endocrinol Metab 61: 1217 - 1219
Heim JM, Gottmann K, Weil J, Haufe MC, Gerzer R (1988) Is cyclic GMP a clini- cally useful marker for ANF action? Z Kardiol 77 [Suppl 2]: 41 - 46
Stasch JP, Hirth C, Kazda S, Wohlfeil S (1986) The elevation of cyclic GMP as a response to acute hypervolemia is blocked by a monoclonal antibody directed against atrial natriuretic peptides. Eur J Pharmacol 129: 165 - 168
Burnett JC, Granger JP, Opgenorth TJ (1984) Effects of synthetic atrial natriuretic factor on rqnal function and renin release. Am J Physiol 247: F863 - F867
Maack T, Marion DN, Camargo MJF, Kleinert HD, Laragh JH, Vaughan ED, Atlas SA (1985) Effects of auriculin (atrial natriuretic factor) on blood pressure, renal function, and the renin-aldosterone system in dogs. Am J Med 77: 1069 - 1075
Brandt RR, Wright RS, Redfield MM, Burnett JC (1993) Atrial natriuretic peptide in heart failure. J Am Coli Cardiol 22 [Suppl A]: 86A - 92A
Feld LG, van Liew JB, Brentjens JR, Boylan JW (1980) Renal lesions and proteinuria in the spontaneously hypertensive rat made normotensive by treatment. Kidney Int 20: 606 - 614
Grammer RT, Fukumi H, Inagami T, Misono KS (1983) Rat atrial natriuretic factor: purification and vasorelaxant activity. Biochem Biophys Res Commun 116: 696 - 703
Neuser D, Knorr A, Stasch JP, Kazda S (1990) Mitogenic activity of endothelin-1 and -3 on vascular smooth muscle cells is inhibited by atrial natriuretic peptides. Artery 17: 311 - 324
Chartier L, Schiffrin E, Thibault G (1984) Atrial natriuretic factor inhibits the Stimulation of aldosterone secretion by angiotensin II, ACTH and potassium in vitro and angiotensin Il-induced steroidgenesis in vivo. Biochem Biophys Res Commun 122: 171-174
Kudo T, Baird A (1984) Inhibition of aldosterone production in the adrenal glomeru- losa by atrial natriuretic factor. Nature 312: 756 - 757
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Knorr, A.M., Hirth-Dietrich, C., Stasch, JP., Kazda, S. (1995). Sinorphan Improves Cardiac Structure and Function in Aged Stroke-Prone Spontaneously Hypertensive Rats. In: Garthoff, B., Knorr, A.M., Busse, WD., Seuter, F. (eds) Experimental Hypertension and Therapeutic Progress: Vasodilation and Beyond. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-79338-7_7
Download citation
DOI: https://doi.org/10.1007/978-3-642-79338-7_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-58545-9
Online ISBN: 978-3-642-79338-7
eBook Packages: Springer Book Archive